FEATURED INSIGHTS
INSIGHTS
FDA Approves Moderna Vaccine
Approval of Moderna's vaccine late Friday under an Emergency Use Authorization by the FDA ensures millions more doses are now en route to distribution centers across the nation. Planes and trucks filled with Moderna's COVID immunization began journeys to distribution centers in every state Sunday morning. Healthcare supply chain giant McKesson is handling the distribution for Moderna from its centers in Kentucky and Mississippi. Pfizer mostly is utilizing the U.S. Government, predominately through the military, for dissemination. McKesson will utilize FedEx and UPS for delivery of its vaccine. Many of the Moderna shipments are being accompanied by local and state police.
Now is the Winter of Our Discontent
Dr. Anthony Fauci has repeatedly said that “the cavalry is coming” when he speaks of the advent of forthcoming vaccines — particularly the two leading contenders, Pfizer/BioNTech and Moderna. But these revolutionary developments utilizing first-ever technology never before applied against a pandemic, or perennial infectious diseases like influenza or measles, won’t be available to quell the overwhelming surge in COVID-19 cases nationwide. Every public health expert is warning the most horrific period of the pandemic has yet to unfold…
COVID Vaccine Distribution: A four-phase plan
Pfizer, in cooperation with German-based BioNTech, crossed an historic milestone this week when they submitted to the Food and Drug Administration an emergency use authorization (EUA) for a COVID-19 vaccine. The data will quickly be analyzed by FDA and then submitted to an independent advisory panel in early December for approval, which then also will receive a necessary ‘green light’ from the Centers for Disease Control, particularly regarding the rollout process for Pfizer/BioNTech’s vaccine on a prioritization scale. Read more…
Transparent COVID Vaccine Key to Public Confidence
There is little question in the scientific community now that Pfizer and Moderna are the two most likely companies to develop viable vaccines — at least at this juncture.
COVID STRATEGY GUIDE: Two Races - Vaccines & the Election
We have learned that a safe, effective vaccine against COVID-19, the infection caused by the coronavirus, most likely won’t be available for large segments of the world’s population until 2022 at the earliest.